Acorda Therapeutics of Hawthorne, New York, has outlined plans to raise $86 million in an IPO. Details of the offering weren't released. Acorda has been developing therapies for multiple sclerosis, spinal cord injuries and other conditions of the central nervous system.
- read this Dow Jones report for more